Glen Olsheim

Glen Olsheim has a diverse work experience spanning over multiple companies and roles. Glen is currently serving as the Executive Director of Commercial Excellence at Outlook Therapeutics, Inc. since January 2023. Prior to this, Glen was the Vice President of Business and New Product Development at Fagron Sterile Services US (FSS) 503B Outsourcing Facility from June 2019 to January 2023. Glen also held the position of Vice President of Ophthalmic Specialties at JCB Laboratories and Fagron Sterile Services from January 2018 to June 2019. Glen's earlier experience includes working as the Chief Financial Officer/Chief Operating Officer at California Pharmacy and Compounding Center from January 2006 to January 2018.

Glen Olsheim pursued a Master of Science in Education (MSED) degree from the University of Southern California from 1999 to 2001.